Corporate News
May 2009
DCL first in Midwest to perform FDA approved HPV Genotyping 
March 16, 2009
DCL Medical Laboratories introduces Reveal Cx™
Breakthrough diagnostic test in risk assessment for cervical cancer
assists physicians in providing individualized care